VYNE Therapeutics
VYNE
#9861
Rank
A$33.55 M
Marketcap
$2.21
Share price
-2.08%
Change (1 day)
-45.13%
Change (1 year)

EPS for VYNE Therapeutics (VYNE)

EPS in 2023 (TTM): -$16.57

According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -$17.27. In 2022 the company made an earnings per share (EPS) of -$11.47 an increase over its 2021 EPS that were of -$40.56.

EPS history for VYNE Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$16.5744.51%
2022-$11.47-71.72%
2021-$40.56-84.19%
2020-$256.57-26.29%
2019-$348.1028.75%
2018-$270.3710.79%
2017-$244.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.41-80.25%๐Ÿ‡บ๐Ÿ‡ธ USA